• TH
    • EN
    • Register
    • Login
    • Forgot Password
    • Help
    • Contact
  • Register
  • Login
  • Forgot Password
  • Help
  • Contact
  • EN 
    • TH
    • EN
View Item 
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Knowledge information in scientific research of virus, diagnostic, treatment and vaccine development

ไตรวิทย์ รัตนโรจน์พงศ์; Triwit Rattanarojpong; วัฒนา พันธุ์พืช; Wattana Panphut; สมปอง ทรัพย์สุทธิภาษ; Sompong Sapsutthipas; ประเวช อรรจวัฒนวงศ์; Pravech Ajawatanawong;
Date: 2564
Abstract
There was an outbreak of SARS-CoV-2, a novel coronavirus, in late December 2019, originated in Wuhan, China. The virus causes problems with the respiratory tract. The syndrome is called "COVID-19". The number of infections and mortality has increased in China within a few weeks after the first patient was discovered. The virus quickly spread globally, including in Thailand. Fortunately, Thailand has an excellent public health policy for handling the outbreak. So we could control the first wave of the epidemic by reduced the infection rate to zero for several months. However, the health systems research institute (HSRI) is looking forward to finding the research direction of COVID-19 for the country. Therefore, this project was funded to review the essential knowledge about the COVID-19 and SARS-CoV-2 for HSRI. The review will be used as basic information for making a policy and manipulating COVID-19 granting in the future. The investigators reviewed the general knowledge of the SARS-CoV-2 that was a causative agent of the COVID-19. The report is divided into five chapters, where Chapter 1 addresses the basic biology of the SARS-CoV-2 virus, including taxonomy, virus structure, genome structure, viral proteins, and virus life cycle. Chapter 2 describes the diagnosis of infection by different test kits. The investigators have identified the key points of the different test kits, the limitations of the use of the diagnostic kits and their interpretation. Chapter 3 summarized all five major types of SARS-CoV-2 antiviral agents, which is currently used. The five grooups of antiviral drugs are (i) anti-enzyme activity of RNA Dependent RNA polymerase (RdRp), (ii) protease inhibitor, (iii) anti-fusion between the viral envelope and the host cell membrane, (iv) the antagonistic binding activity between the virus and host cell surface and receptors, and (v) anti-interleukine-6 receptor. Chapter 4 is focused on the immune system responding to SARS-CoV-2 virus infection. Chapter 5 will address the opinions of researchers, who are working on COVID-19 research over time of outbreak. The investigators wish the information of this report would be helpful for HSRI to be used in country policy-making for COVID-19 funding.
Copyright ผลงานวิชาการเหล่านี้เป็นลิขสิทธิ์ของสถาบันวิจัยระบบสาธารณสุข หากมีการนำไปใช้อ้างอิง โปรดอ้างถึงสถาบันวิจัยระบบสาธารณสุข ในฐานะเจ้าของลิขสิทธิ์ตามพระราชบัญญัติสงวนลิขสิทธิ์สำหรับการนำงานวิจัยไปใช้ประโยชน์ในเชิงพาณิชย์
Fulltext
Thumbnail
Name: hs2663.pdf
Size: 3.541Mb
Format: PDF
Download

User Manual
(* In case of download problems)

Total downloads:
Today: 0
This month: 0
This budget year: 10
This year: 2
All: 1,634
 

 
 


 
 
Show full item record
Collections
  • Research Reports [2469]

    งานวิจัย


DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

HSRI Knowledge BankDashboardCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjectsSubjectsการบริการสุขภาพ (Health Service Delivery) [619]กำลังคนด้านสุขภาพ (Health Workforce) [99]ระบบสารสนเทศด้านสุขภาพ (Health Information Systems) [286]ผลิตภัณฑ์ วัคซีน และเทคโนโลยีทางการแพทย์ (Medical Products, Vaccines and Technologies) [125]ระบบการเงินการคลังด้านสุขภาพ (Health Systems Financing) [158]ภาวะผู้นำและการอภิบาล (Leadership and Governance) [1281]ปัจจัยสังคมกำหนดสุขภาพ (Social Determinants of Health: SDH) [228]วิจัยระบบสุขภาพ (Health System Research) [28]ระบบวิจัยสุขภาพ (Health Research System) [20]

DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV